UroGen Pharma's shares fell about 30% following a 208% rally driven by the successful launch of Zusduri, the only approved non-surgical therapy for LG-IR-NMIBC bladder cancer. Zusduri's rapid market uptake, strong clinical data, patient preference, and patent protection until 2044 support continued growth. Despite potential future competition, UroGen currently faces only surgical treatment alternatives, positioning it for robust growth through at least 2027. Analysts forecast significant earnings growth and a $1 billion portfolio by 2030, making the recent stock pullback an attractive entry point for investors.
UroGen Pharma stock is the subject, with Pluang's Health-sector market data as context. As of Oct 13, 2026 18:02 WIB, among 128 priced Health-sector US stocks tradable on Pluang, 78 rose and 41 fell. Notable movers include CGC at USD 0.75 with a 1-day change of -1.58%, NUWE at USD 0.66 down 1.54%, and DNA at USD 11.61 down 1.53%. The most notable figure is that 78 stocks rose today.
Schrödinger's stock fell 5.02% to $25.91 despite co-founding Tectora, a new biopharma venture with $55 million funding targeting immune and inflammatory treatments. The company, known for its molecular modeling software, holds a market value of about...
Johnson & Johnson reported third-quarter 2026 earnings per share of $2.59, surpassing analyst estimates of $2.52, with total revenue of $25.40 billion slightly above expectations. The company saw robust growth in its pharmaceutical segment, which off...
TSMC's preliminary Q3 2026 revenue reached approximately NT$1.49 trillion, about 50% higher year-over-year and above management guidance, driven by strong AI chip demand. The company holds a dominant 73% share of the global pure-play foundry market, ...
Inc. and SurveyMonkey have launched Growth Signals, a new initiative to regularly poll entrepreneurs and business leaders of fast-growing companies. This program aims to capture their priorities, challenges, and growth outlook to inform Inc.'s editor...
BNB Standard Corporation has launched a new corporate website featuring an expanded treasury dashboard that updates its Adjusted Net Asset Value and other key financial metrics intraday. This move aims to increase transparency and accountability in t...
